ETR:AFX

Carl Zeiss Meditec - AFX Stock Forecast, Price & News

€134.35

-3.80 (-2.75%)

(As of 03/20/2023 12:00 AM ET)

Add

Compare

Today's Range: €134.35
▼
€139.00
50-Day Range: €126.00
▼
€142.10
52-Week Range: €101.75
▼
€152.35

Volume: 76,739 shs
Average Volume: 94,405 shs
Market Capitalization: $12.02 billion

P/E Ratio: 49.03
Dividend Yield: 0.82%
Price Target: €177.00

About Carl Zeiss Meditec (ETR:AFX) Stock

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers offers products and solutions for the diagnosis and treatment of chronic eye diseases; and systems and consumables for refractive surgery. This segment also provides slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras used for the examination of the retina in hospitals and practices; and equipment for functional diagnostics. In addition, this segment offers surgical microscopes, biometers, and phacoemulsification or vitrectomy devices; and intraocular lenses for cataract patients. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

Receive AFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter.

AFX Stock News Headlines

February 4, 2023 | finance.yahoo.com

With EPS Growth And More, Carl Zeiss Meditec (ETR:AFX) Makes An Interesting Case

December 29, 2022 | finance.yahoo.com

Carl Zeiss Meditec (ETR:AFX) Is Paying Out A Larger Dividend Than Last Year

March 21, 2023 | Weiss Ratings (Ad)

Urgent Warning

This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …

December 1, 2022 | finance.yahoo.com

Carl Zeiss Meditec's (ETR:AFX) five-year total shareholder returns outpace the underlying earnings growth

November 17, 2022 | finance.yahoo.com

When Should You Buy Carl Zeiss Meditec AG (ETR:AFX)?

November 1, 2022 | finance.yahoo.com

Private companies who hold 59% of Carl Zeiss Meditec AG (ETR:AFX) gained 4.3%, institutions profited as well

August 31, 2022 | finanznachrichten.de

Carl Zeiss Meditec AG: ZEISS Integrated Workflow Solutions are Creating the Digital Transformation in Healthcare

August 5, 2022 | nasdaq.com

Carl Zeiss Meditec 9-month Operating Result Slightly Declines

March 21, 2023 | Weiss Ratings (Ad)

Urgent Warning

April 8, 2022 | finanznachrichten.de

Carl Zeiss Meditec AG: ZEISS to Unveil Clinical Insights Supporting the Value of New Data-Driven Digital Workflow Solutions and Software Applications

July 4, 2021 | finance.yahoo.com

CARL ZEISS MEDITEC AG (AFX.DE) stock forecast and price target

June 14, 2021 | bizjournals.com

After passing Covid test, Peninsula diagnostics company refocuses on the eye with new CEO

April 14, 2021 | marketwatch.com

Near-Infrared Imaging Market Size Worth USD 1,535.0 Million in 2028, Market Trends – Increasing geriatric population

February 12, 2021 | marketwatch.com

Medical Device Contract Manufacturing Market Size, Share to Grow Tremendously During 2020-2027 Industry News | ARC

February 9, 2021 | seekingalpha.com

Carl Zeiss Meditec AG (CZMWF) CEO Ludwin Monz on 3-Months Quarterly Statement Conference Call 2021 Results - Earnings Call Transcript

January 26, 2021 | marketwatch.com

Intraoperative Radiation Therapy Systems Market Development by Gross Margin, Market Share, CAGR, and Influencing Factors and Forecast To 2025

January 19, 2021 | nasdaq.com

Carl Zeiss Meditec Q1 Profit Rises - Quick Facts

January 2, 2021 | marketwatch.com

Ophthalmic Ultrasound Systems Market (2020-29): Product Analysis, Market Statistics and Immense Report | Ametek Inc, Carl Zeiss Meditec AG

December 11, 2020 | seekingalpha.com

Carl Zeiss Meditec AG (CZMWF) CEO Ludwin Monz on Q4 2020 Results - Earnings Call Transcript

November 11, 2020 | marketwatch.com

Medical Workstations Market Growth Opportunities, Industry Analysis, Size, Share, Geographic Segmentation Till 2027 By Reports And Data

November 9, 2020 | marketwatch.com

Multifocal Intraocular Lens Market 2020 includes Size, Share, Impact of COVID-19, Trends and Forecast to 2026 Research Report by Absolute Reports

October 29, 2020 | nasdaq.com

Carl Zeiss Meditec Q4 EBIT Declines - Quick Facts

October 17, 2020 | ca.finance.yahoo.com

CARL ZEISS MEDITEC AG (AFX.MU)

October 16, 2020 | ca.finance.yahoo.com

CARL ZEISS MEDITEC AG (AFX.DU)

August 16, 2020 | ca.finance.yahoo.com

Carl Zeiss Meditec AG Inhaber-A (AFX.SG)

July 20, 2020 | www.marketwatch.com

South Korean Ophthalmic Devices Market Demand, Production and Company Overview to 2025

July 15, 2020 | www.nasdaq.com

Carl Zeiss Meditec 9-month EBIT Declines; Adj. Revenue Down 6.9% - Quick Facts

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive AFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carl Zeiss Meditec and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: ETR
Industry: Diagnostics & Research
Sub-Industry: N/A
Sector: Medical
Current Symbol: ETR:AFX
CUSIP: N/A
CIK: N/A
Web: www.zeiss.com
Phone: +49-3641-2200
Fax: N/A
Employees: 3,531
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: €177.00
High Stock Price Forecast: €215.00
Low Stock Price Forecast: €138.00
Forecasted Upside/Downside: +31.7%
Consensus Rating: N/A
Rating Score (0-4): 0.00
Research Coverage: 0 Analysts

Profitability

EPS (Most Recent Fiscal Year): €2.74
Trailing P/E Ratio: 49.03
Forward P/E Ratio: 36.56
P/E Growth: 4.05
Net Income: $307.01 million
Net Margins: 15.64%
Pretax Margin: N/A
Return on Equity: 16.64%
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 6.30
Current Ratio: 3.32
Quick Ratio: 2.47

Sales & Book Value

Annual Sales: $1.96 billion
Price / Sales: 6.13
Cash Flow: €0.10 per share
Price / Cash Flow: 1,398.28
Book Value: €22.53 per share
Price / Book: 5.96

Miscellaneous

Outstanding Shares: 89,440,000
Free Float: N/A
Market Cap: $12.02 billion
Optionable: Not Optionable
Beta: 0.80

Key Executives

Mr. Justus Felix Wehmer (Age 57)
CFO & Member of the Management Board
Comp: $564.5k

Dr. Markus Weber
Pres, CEO & Chairman of Management Board

Mr. Sebastian Frericks
Director of Investor Relations

Mr. Martin Wiechmann
Head of the Planetarium Bus. Unit

Mr. Mike Wang
Head of Marketing - Shanghai

Mr. Steven C. Schallhorn M.D.
Chief Medical Officer for Global Ophthalmic Devices

Mr. Andrew Chang
Head of Sales for Ophthalmic Devices & Pres of Carl Zeiss Meditec, Inc.

Laurie Ferguson
Head of Global Communications Ophthalmic Devices

Dr. Euan S. Thomson Ph.D. (Age 59)
Pres of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Bus. Unit

Mr. Magnus Reibenspiess
Head of the Microsurgery Strategic Bus. Unit - ZEISS Medical Technology

Key Competitors

View All Competitors

AFX Stock - Frequently Asked Questions

What is Carl Zeiss Meditec's stock price forecast for 2023?: 0 brokerages have issued 12-month target prices for Carl Zeiss Meditec's stock. Their AFX share price forecasts range from €138.00 to €215.00. On average, they predict the company's share price to reach €177.00 in the next year. This suggests a possible upside of 31.7% from the stock's current price.
View analysts price targets for AFX or view top-rated stocks among Wall Street analysts.
How have AFX shares performed in 2023?: Carl Zeiss Meditec's stock was trading at €117.90 at the start of the year. Since then, AFX shares have increased by 14.0% and is now trading at €134.35.
View the best growth stocks for 2023 here.
Is Carl Zeiss Meditec a good dividend stock?: Carl Zeiss Meditec (ETR:AFX) pays an annual dividend of €1.10 per share and currently has a dividend yield of 0.80%. The dividend payout ratio is 40.15%. This payout ratio is at a healthy, sustainable level, below 75%.
What other stocks do shareholders of Carl Zeiss Meditec own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Carl Zeiss Meditec investors own include Covestro (1COV), AbbVie (ABBV), AmerisourceBergen (ABC), Allianz (ALV), Daimler (DAI), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM) and SAP (SAP).

What is Carl Zeiss Meditec's stock symbol?: Carl Zeiss Meditec trades on the ETR under the ticker symbol "AFX."
What is Carl Zeiss Meditec's stock price today?: One share of AFX stock can currently be purchased for approximately €134.35.
How much money does Carl Zeiss Meditec make?: Carl Zeiss Meditec (ETR:AFX) has a market capitalization of $12.02 billion and generates $1.96 billion in revenue each year. The company earns $307.01 million in net income (profit) each year or €2.74 on an earnings per share basis.
How many employees does Carl Zeiss Meditec have?: The company employs 3,531 workers across the globe.
How can I contact Carl Zeiss Meditec?: Carl Zeiss Meditec's mailing address is Goeschwitzer Strasse 51-52, JENA, 07745, Germany. The official website for the company is www.zeiss.com. The company can be reached via phone at +49-3641-2200.

This page (ETR:AFX) was last updated on 3/21/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial